Unknown

Dataset Information

0

Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines.


ABSTRACT: Targeted genome engineering to robustly express transgenes is an essential methodology for stem cell-based research and therapy. Although designer nucleases have been used to drastically enhance gene editing efficiency, targeted addition and stable expression of transgenes to date is limited at single gene/locus and mostly PPP1R12C/AAVS1 in human stem cells. Here we constructed transcription activator-like effector nucleases (TALENs) targeting the safe-harbor like gene CLYBL to mediate reporter gene integration at 38%-58% efficiency, and used both AAVS1-TALENs and CLYBL-TALENs to simultaneously knock-in multiple reporter genes at dual safe-harbor loci in human induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs). The CLYBL-TALEN engineered cell lines maintained robust reporter expression during self-renewal and differentiation, and revealed that CLYBL targeting resulted in stronger transgene expression and less perturbation on local gene expression than PPP1R12C/AAVS1. TALEN-mediated CLYBL engineering provides improved transgene expression and options for multiple genetic modification in human stem cells.

SUBMITTER: Cerbini T 

PROVIDER: S-EPMC4294658 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines.

Cerbini Trevor T   Funahashi Ray R   Luo Yongquan Y   Liu Chengyu C   Park Kyeyoon K   Rao Mahendra M   Malik Nasir N   Zou Jizhong J  

PloS one 20150114 1


Targeted genome engineering to robustly express transgenes is an essential methodology for stem cell-based research and therapy. Although designer nucleases have been used to drastically enhance gene editing efficiency, targeted addition and stable expression of transgenes to date is limited at single gene/locus and mostly PPP1R12C/AAVS1 in human stem cells. Here we constructed transcription activator-like effector nucleases (TALENs) targeting the safe-harbor like gene CLYBL to mediate reporter  ...[more]

Similar Datasets

| S-EPMC4412852 | biostudies-literature
| S-EPMC3844088 | biostudies-literature
| S-EPMC7297435 | biostudies-literature
| S-EPMC2819713 | biostudies-literature
| S-EPMC3090697 | biostudies-literature
| S-EPMC3374894 | biostudies-literature
| S-EPMC6499654 | biostudies-literature
| S-EPMC3799456 | biostudies-other
| S-EPMC4309836 | biostudies-other
| S-EPMC3776314 | biostudies-literature